Prevention of perioperative deep vein thrombosis in general surgery: A multicentre double blind study comparing two doses of Logiparin and standard heparin

British Journal of Surgery

Volumn 78, Issue 4, 1991, Pages 412-416

  Liezorovicz, A ^a   Picolet, H ^a   Peyrieux, J C ^a   Boissel, J P ^a  

^a HÔPITAL NEUROLOGIQUE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; TINZAPARIN;

ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FEMALE; GENERAL SURGERY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THROMBOSIS PREVENTION;

ADULT; BLOOD LOSS, SURGICAL; COMPARATIVE STUDY; DOUBLE-BLIND METHOD; FEMALE; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMAN; INJECTIONS, SUBCUTANEOUS; MALE; MIDDLE AGE; POSTOPERATIVE COMPLICATIONS; THROMBOPHLEBITIS;

EID: 0025877941     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.1800780410     Document Type: Article

References (11)

1. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous herparin
2. Efficacy and safety of low‐molecular‐weight heparin (CY216) in preventing postoperative venous thromboembolism: a cooperative study
3. A randomized controlled trial of a low molecular weight heparin (Enoxaparin) to prevent deep vein thrombosis in patients undergoing elective hip surgery
4. Comparison of a low molecular weight heparin and unfractionated heparin in the prevention of deep venous thrombosis in patients undergoing abdominal surgery
5. Low molecular weight heparin once daily compared with conventional low dose heparin twice daily. A prospective double blind multicentre trial on prevention of postoperative thrombosis
6. A French Multicenter Trial. A randomized double blind study of a low molecular weight heparin (KABI 2165) once daily and low dose standard heparin twice daily in the prevention of postoperative deep vein thrombosis in general surgery
7. Clinical studies with low molecular weight heparins in the prevention and treatment of venous thromboembolism
8. Thrombosis prophylaxis in visceral surgery with the low molecular weight heparin fragment Kabi 2165 (7500 and 2500 anti‐Xa IU/day)
9. 125I‐fibrinogen uptake test for diagnosis of established venous thrombosis in heparinized patients
10. Diagnosis of deep‐thrombosis
11. Diagnosis of venous thrombosis in the lower limbs